Trials / Completed
CompletedNCT00491114
Intravesical Chemotherapy Treatment of Superficial Bladder Cancer
Intravesical Gemcitabine Therapy in Intermediate Risk Superficial Bladder Cancer: A Phase II Study With the Marker Lesion
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase II study where chemotherapy (gemcitabine) is given into the urinary bladder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gemcitabine |
Timeline
- Start date
- 2003-07-01
- Completion
- 2004-08-01
- First posted
- 2007-06-25
- Last updated
- 2007-06-25
Locations
7 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00491114. Inclusion in this directory is not an endorsement.